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Abstract
Background—Increasing evidence suggests that oral microbiota play a pivotal role in chronic
diseases, in addition to the well-established role in periodontal disease. Moreover, recent studies
suggest that oral bacteria may also be involved in carcinogenesis; periodontal disease has been
linked several cancers. In this study, we examined whether lifestyle factors have an impact on
antibody levels to oral bacteria.
Methods—Data on demographic characteristics, lifestyle factors, and medical conditions were
obtained at the time of blood sample collection. For the current analysis, we measured antibody
levels to 25 oral bacteria in 395 cancer-free individuals using an immunoblot array. Combined
total immunglobin G (IgG) levels were obtained by summing concentrations for all oral bacteria
measured.
Results—IgG antibody levels were substantially lower among current and former smokers (1697
and 1677 ng/mL, respectively) than never smokers (1960 ng/mL; p-trend = 0.01), but did not vary
by other factors, including BMI, diabetes, physical activity, or by dietary factors, after adjusting
for age, sex, education, country and smoking status. The highest levels of total IgG were found
among individuals with low education (2419 ng/mL).
Conclusions—Our findings on smoking are consistent with previous studies and support the
notion that smokers have a compromised humoral immune response. Moreover, other major
factors known to be associated with inflammatory markers, including obesity, were not associated
with antibody levels to a large number of oral bacteria.
Introduction
Within the oral cavity, more than 700 different bacterial species or phylotypes inhabit a
complicated ecosystem that remains in dynamic equilibrium1, 2. This ecological equilibrium
is marked by the stable and diverse composition of the bacterial community and maintains
the health of the oral cavity3, 4. Disruptions of this balance can promote the growth of
opportunistic strains and disrupt the relationship between the microbes and the human host5.
Increasing evidence indicates that oral microbiota play a pivotal role in chronic diseases;
poor oral health (including periodontal disease and tooth loss) has been associated with
respiratory disease6, cardiovascular diseases7, stroke8, 9, rheumatoid arthritis10,
diabetes11, 12, head and neck cancer12, 13, pancreatic cancer14, 15, colon cancer16, 17, and
orodigestive cancers18.
Lifestyle, diet and disease status influence the host in different ways. Studies have
consistently shown that smokers have lower immunoglobulin G (IgG) levels to oral bacteria,
suggesting that smoking suppresses the humoral immune response19, 20. While obesity and
diabetes can impact the innate immune response21, 22, it is less clear whether these
conditions can impact the humoral immune response, and specifically the immune response
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to oral bacteria. No study has examined the relationship between dietary factors and IgG
levels to oral bacteria in blood. A few studies observed that diet can influence bacteria in the
mouth suggesting that it may impact the mounted immune response to these bacteria; for
example, coffee and wine have strong anti-bacterial and anti-adhesive properties23, cocoa
can reduce bacterial polysaccharide production24, sugars and acidic foods favor aciduric
bacterial species25, and yogurt may inhibit periodontal pathogens26. Furthermore, certain
foods are rich in antioxidants and may influence the immune response by lowering levels of
oxidative stress, a significant modifier of immune mechanisms. In one study, high levels of
systemic oxidative stress were strongly associated with lower total IgG levels, after
controlling for a large number of known cardiovascular risk factors27.
Understanding the association between lifestyle factors and antibodies to oral bacteria may
provide new insights into the interaction between the environment and the host immune
response to pathogens. We measured antibodies to 25 oral bacteria and examined their
association with lifestyle factors, including smoking, physical activity, obesity and diabetes,
and dietary factors previously linked to oral bacteria, in a population study of cancer-free
individuals.
Materials and Methods
Study Population
The European Prospective Investigation into Cancer and Nutrition (EPIC) includes 519,978
participants, mostly aged 35–70 years, who were recruited in 23 centers within 10 European
countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain,
Sweden, and the United Kingdom) between 1992 and 2000. Detailed descriptions of the
study design, population, and baseline data collection of the cohort can be found in a
previous report28. Each participant provided informed consent. The local ethical review
committees approved the EPIC cohort study as well as the current project. For this analysis,
we included 395 cancer-free control subjects (i.e., no known medical conditions at the time
of blood draw and no major chronic diseases diagnosed during follow-up) who had available
antibody measurements for 25 oral bacteria (see previous study15). In all but three countries
(Denmark, Norway and Sweden), blood samples were collected based on a standardized
protocol and aliquoted in plastic straws (plasma, serum, erythrocytes, and buffy coat for
DNA). The aliquoted specimens were then stored in a central biorepository (IARC, France)
in liquid nitrogen (−196°C). In Sweden, all samples were stored locally in freezers at −80°C
and in Denmark in nitrogen vapour (−150°C). Due to small numbers (n=2), samples from
Norway were excluded from this analysis.
Antibody detection
Plasma content of IgG antibodies against a panel of 25 bacterial species/strains selected for a
prior study examining the relation between periodontal disease and pancreatic cancer15.
Measurements were conducted using an immunoblot array as described previously15, 29.
This method has the advantage of using a very small amount of primary sample (less than 10
μl). Briefly, whole-cell formalin fixed bacteria suspensions and protein A from
Staphylococcus aureus (control) were used as antigens. Plasma samples (diluted 1:125), and
serial dilutions of human IgG immunoglobulin (250, 125, 62.5, 30, 15, and 7.5 ng/ml) were
applied to the perpendicular lanes of the immunoblotter. Bound IgG was detected by anti-
human IgG antibody. Plasma IgG concentrations were estimated by using the human IgG
immunoglobulin reference curve. The lower detection limit of the method was 3.0 ng/ml and
interassay correlations were previously reported to be good (percent concordance between
0.67 and 0.8415).
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Diet and lifestyle questionnaires
Dietary and lifestyle questionnaires were completed by participants at enrolment. Diet was
assessed using country-specific, validated questionnaires designed to capture habitual
consumption of food over the preceding year30. Extensive quantitative dietary
questionnaires with up to 260 food items were used in northern Italy, The Netherlands,
Germany, Greece, France and Spain. Semi-quantitative food frequency questionnaires were
used in Denmark, Norway, Umeå (Sweden), and Naples (Italy). Combined dietary methods
of food records and questionnaires were used in the UK and Malmö (Sweden)28.
Lifestyle questionnaires included questions on education, occupation, medical history,
lifetime history of consumption of tobacco, alcoholic beverages and physical activity28.
Height and weight were measured directly in most centres at recruitment; self-reported
height and weight were obtained in France and at one centre in the United Kingdom. Body
mass index (BMI) was calculated as kg/m2. Waist circumference was measured either at the
narrowest torso circumference (Italy; Cambridge, United Kingdom; and Utrecht, the
Netherlands) or at the midpoint between the lower ribs and iliac crest (Bilthoven, the
Netherlands; Potsdam, Germany; Malmö, Sweden; and Oxford, United Kingdom). In Spain,
Greece, Denmark, and Heidelberg, Germany, a combination of methods was used, although
the majority of participants were measured at the narrowest circumference. Hip
circumference was measured at the widest circumference (Italy; Spain; Bilthoven, the
Netherlands; Greece; and Malmö, Sweden) or over the buttocks (United Kingdom; Utrecht,
the Netherlands; Germany; and Denmark).
Statistical Analysis
Total IgG level was estimated by summing together the antibody concentration to 25 oral
bacteria. A transformation (square root) was conducted to obtain a normal distribution of
this variable. We used generalized linear models (GLM) to estimate marginal means (LS
Means) and p-values are based on the Type III F-test; major demographic, lifestyle and
dietary factors were modelled simultaneously to examine the independent contribution of
each. We created quartiles for dietary variables and for the waist-to-hip ratio. Mean values
were squared to obtain interpretable measures (total IgG in ng/ml). We used a generalized
linear model with binomial distribution (PROC GENMOD, LOGIT LINK) to obtain
proportions of individuals with elevated antibodies (defined as >200ng/ml; >50 ng/ml; or
>7.5 ng/ml, depending on prevalence of values in the higher categories) within different
strata of smoking (never, former, current) controlling for age, sex, country of origin and
education. This analysis was repeated for education, controlling for smoking status. P-values
were based on tests for trend (ordered categorical variables modelled as continuous). All
statistical analyses were conducted using the Statistical Analysis System (SAS) software
package, Version 9.2 (SAS Institute Inc., Cary, North Carolina, USA).
Results
In this cancer-free population, we observed a statistically significant association between
smoking status and total IgG (p = 0.01); never smokers had higher total IgG levels than
former and current smokers (Table 1) after adjusting for potential confounding variables
(i.e., sex, age, country and education). Males had higher antibody level than females
(p=0.02), and an inverse relationship was observed between education and total IgG levels
(p=0.003). No statistically significant association was observed for total IgG levels and age,
BMI, waist-to-hip ratio, diabetes, hypertension, hyperlipidemia, or physical activity (Table
1). Mean total IgG levels were higher among subjects with low education who were never
smokers (2536 ng/ml), compared with subjects with low education who were ever smokers
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(2056 ng/ml); the difference between smokers and nonsmokers was similar across
educational level (data not shown).
Three of the five oral bacterial pathogens previously associated with periodontal disease
were significantly associated with smoking status (P. gingivalis ATCC 33277, p = 0.03;
Aggregatibacter actinomycetemcomitans ATCC 29523, p=0.02; Tannerella forsythia,
p=0.003; Table 2) after adjusting for potential confounders; antibody levels to these oral
pathogens were lower in smokers than in never smokers. For A. actinomycetemcomitans
ATCC 43718, an inverse association was observed between IgG levels and smoking status,
but the association did not reach statistical significance (p=0.17). Half of the antibodies to
Gram-negative oral bacterial species measured in this study were associated with smoking
status (in addition to the pathogenic strains: Fusobacterium polymorphum, p = 0.004;
Prevotella intermedia, p=0.02; Prevotella melaninogenica, p=0.01; Prevotella nigrescens, p
< 0.001). None of the antibodies to the Gram-positive bacteria were associated with smoking
status after adjusting for potential confounders (Table 2).
After adjusting for potential confounders, including smoking, statistically significant
associations were observed between education and IgG levels, such that having lower
education was associated with higher levels of antibodies to P. gingivalis ATCC 33277, P.
intermedia, P. melaninogenica, and P. nigrescens (Supplemental Table).
Quartiles of consumption of vegetables, fruits, vitamin C, dairy products, alcohol, and coffee
were evaluated in relation to total IgG levels (Table 3); no associations were noted for these
dietary factors. Additionally, total IgG levels for the consumption of tea, wine, yogurt, sugar
and meats were examined separately, but no associations were observed.
Total IgG levels were not associated with BMI in this population. However, given that T.
forsythia levels were reported to be significantly higher in subgingival biofilm of obese
individuals in a recent study31, we examined the association between these antibodies and
BMI separately. While the association was not statistically significant (p-value = 0.18),
overweight subjects had more elevated antibodies to T. forsythia (>50 ng/ml; 17.9%)
compared to those with BMI<25 kg/m2 (12.8%), adjusting for potential confounders.
Discussion
In this large cross-sectional analysis of cancer-free individuals living throughout Europe, we
observed lower overall antibody levels to 25 oral bacteria in current smokers compared to
never smokers, women compared to men, and individuals with higher education compared
to lower education. Antibody levels associated with smoking status included antibodies to a
number of periodontal pathogens and other Gram-negative bacteria. Antibody levels
associated with education were similarly associated with Gram-negative bacteria. No
differences in overall antibody levels were noted by age, obesity, diabetes, physical activity,
and a number of dietary factors, including fruit and vegetable consumption.
An association between oral bacteria and systemic antibody response is well-established in
individuals who have different degrees of periodontal disease; serum antibody levels to oral
pathogens, such as P. gingivalis, correlate with severity of periodontal disease32. However,
in the general population, the association between serum antibody levels to oral pathogenic
bacteria and periodontal disease status is inconsistent; other factors, such as smoking status,
can influence the immune response (i.e., IgG levels)19, 20. Additionally, most studies on
antibody response to oral bacteria have been performed on small numbers of patients with
periodontitis, which limits interpretation to the general population. To date, two large
population studies examined the relation between antibody levels to a number of oral
bacteria and periodontal disease status. In a study of 8153 individuals (NHANES III), P.
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gingivalis antibodies were the only antibodies (out of 19 species) that were significantly
correlated to periodontal disease status (positive associations measured with two different
definitions of periodontitis)19. In the other study, conducted in the Atherosclerosis Risk in
Communities study (ARIC) and including 4,717 individuals, higher total IgG levels to 17
commensal oral bacteria were observed in those with more severe periodontal disease27.
Smoking has been consistently shown to suppress the humoral immune response20. Total
IgG levels have been observed to be lower among current smokers33, and approximately
half of IgG levels to specific oral bacteria were also lower in current smokers in a large
population based study19. In the present study, we also observed that about half of IgG
levels to oral bacteria were significantly lower among current smokers.
Dietary intake has been associated with oral bacteria measured directly in saliva and plaques
of healthy subjects23. Individuals consuming large quantities of coffee, tea or wine, had
lower levels of pathogenic bacteria in saliva and plaque than those drinking primarily
water23; however, the same study made no statistical adjustment for potential confounders,
including smoking status. Studies on diet and periodontal disease suggest that whole
grains34 may lower risk of periodontal disease, but overall findings with diet are
inconsistent35. Dietary factors in our study were not associated with total antibody levels or
with antibodies to pathogenic bacteria.
The relation between oral bacteria and obesity was previously examined in one study.
Levels of T. forsythia measured in subgingival biofilm of subjects with periodontally
healthy gums, or exhibiting gingivitis (n=120), were significantly higher among those who
were obese (r=0.43, p<0.001), but other bacteria were not associated with obesity 31. No
association was noted for other pathogenic or commensal bacteria. While we did observe
higher levels of antibodies to T. forsythia among overweight individuals, compared to
normal weight (BMI <25 kg/m2), the association was not statistically significant. Unlike
smoking, total antibody IgG levels were not associated with BMI in our population.
Systemic oxidative stress has been shown to be more strongly associated with total oral
bacteria antibodies than periodontal disease status, smoking or other demographic and
lifestyle factors in a large population study 27. This finding highlights the need for more
studies on modulators of the immune response to bacterial pathogens. Although we did not
have any measure of oxidative stress in our study population to examine this question, intake
of foods high in antioxidants, including fruits and vegetables, was not related to antibody
levels. More studies are also needed to understand factors that impact oxidative stress
markers and the humoral immune response.
The major limitation of our study was the lack of data on periodontal disease status. Another
limitation was the large differences in antibody levels by country which were not
attributable to major lifestyle and medical factors examined. The differences therefore
remain unexplained and may have influenced our results. However, the observed association
between antibodies for periodontal pathogens and education, and the findings for smoking
status, provide some indirect validation of the assays we conducted, given consistency with
prior studies.
Our data are consistent with previous studies demonstrating suppressed immune response
among smokers. Although obesity and diabetes can modulate the innate immune response,
we observed no association with antibodies to oral bacteria in this study; however, as the
number of diabetics in this study was low (n=17) more studies will need to confirm this
finding. Similarly, consumption of antioxidant rich foods, or foods known to modulate
bacteria colonization in the mouth, were not related to plasma levels of oral bacteria
antibodies.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Total antibody measured to 25 oral bacteria in apparently healthy individuals in the EPIC sub-cohort (n=395)
in relation to baseline characteristics and lifestyle factors.
Numbers (%) Total IgG (ng/mL)* P-values**
Sex 0.02
 Males 187 (47) 1892
 Females 208 (53) 1663
Age (years) 0.79
 <50 53 (13) 1716
 50–59 166 (42) 1801
 ≥60 176 (45) 1811
Smoking status 0.01
 Never 174 (44) 1960
 Former 134 (34) 1677
 Current 87 (22) 1697
BMI (kg/m2) 0.41
 <25 171 (43) 1693
 25–<30 162 (41) 1809
 ≥30 62 (16) 1827
Waist-to-hip ratio § 0.61
 Quartile 1 83 (23) 1863
 Quartile 2 97 (27) 1734
 Quartile 3 91 (25) 1811
 Quartile 4 90 (25) 1688
Education 0.003
 None 17 (4) 2419
 Primary school completed 147 (37) 1662
 Technical/professional school 104 (26) 1839
 Secondary school 54 (14) 1520 18
 Higher education 73 (19) 1511
Country <0.001
 Denmark 82 (21) 1020
 France 15 (4) 2314
 Germany 52 (13) 1803
 Greece 22 (6) 1972
 Italy 38 (10) 2009
 The Netherlands 38 (10) 1548
 Spain 28 (7) 2095
 Sweden 82 (21) 1529
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Numbers (%) Total IgG (ng/mL)* P-values**
 United Kingdom 38 (10) 1876
Physical activity # 0.90
 Inactive 106 (30) 1686
 Moderatively inactive 123 (34) 1761
 Moderatively active 66 (18) 1781
 Active 65 (18) 1784
Diabetes $ 0.20
 No 362 (96) 1799
 Yes 17 (4) 1525
Hypertension $ 0.94
 No 205 (70) 1829
 Yes 80 (27) 1836
Hyperlipidemia $ 0.72
 No 183 (65) 1823
 Yes 66 (35) 1739
*Sum of IgG measured for 25 oral bacteria.
**p-values mutually adjusted for other variables in this table (physical activity, waist-to-hip ratio, and diabetes, hypertension and hyperlipidemia
not adjusted for to maintain sample size of 395).
§Quartiles: males, <0.90, 0.90 to <0.93, 0.94 to <1.0, and ≥1.0; females, <0.76, 0.76 to <0.81, 0.79 to <0.85, and ≥0.85; 36 with missing data for
wait-to-hip ratio.
#Among 360 individuals with data on physical activity.
$
Missing data: 16 for diabetes; 110 for hypertension; 146 for hyperlipidemia.
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Table 2
Percent individuals with elevated antibody levels to oral bacteria by smoking status*.
Bacteria % with high IgG level§ P-values
Never smokers Past smokers Current smokers
Oral periodontal pathogens** (Gram negative)
 Porphyromonas gingivalis
 ATCC 33277
26.2 14.6 13.8 0.03
 Porphyromonas gingivalis
 ATCC 53978‡
38.4 30.7 36.7 0.17
 Aggregatibacter actinomycetemcomitans
 ATCC 29523
31.9 22.3 17.2 0.02
 Aggregatibacter actinomycetemcomitans
 ATCC 43718
31.9 26.4 21.8 0.17
 Tannerella forsythia
 ATCC 43037‡
27.2 11.5 12.7 0.003
Oral bacterial species of the human microbiome (Gram negative)
 Fusobacterium nucleatum
 ATCC 25586‡
37.9 27.0 35.2 0.52
 Fusobacterium periodonticum
 ATCC 33693^
5.5 3.1 4.5 0.39
 Fusobacterium polymorphum
 ATCC 10953^
48.3 34.2 26.5 0.004
 Prevotella intermedia
 ATCC 25611‡
60.3 40.1 46.0 0.02
 Prevotella melaninogenica
 ATCC 25845‡
73.7 62.1 57.3 0.01
 Prevotella nigrescens
 ATCC 33563‡
81.3 70.8 59.4 <0.001
 Veillonella atypica
 ATCC 17744‡
9.8 6.9 8.1 0.55
 Veillonella parvula
 ATCC 10790‡
23.1 17.5 20.2 0.49
Oral bacterial species of the human microbiome (Gram positive)
 Bifidobacterium dentium
 ATCC 27534^
48.8 39.7 40.0 0.20
 Corynebacterium matruchotii
 ATCC 14266^
56.0 47.8 42.9 0.09
 Enterococcus faecalis
 ATCC 29212‡
8.7 7.0 5.7 0.34
 Parvimonas micra
 ATCC 33270
63.2 48.1 63.5 0.69
 Peptostreptococcus anaerobius
 ATCC 27337^
7.5 5.4 4.9 0.35
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Bacteria % with high IgG level§ P-values
Never smokers Past smokers Current smokers
 Streptococcus intermedius
 ATCC 27335‡
36.5 28.5 35.4 0.68
 Streptococcus mitis
 ATCC 49456
48.1 45.4 57.3 0.27
 Streptococcus salivarius
 ATCC 7073
10.9 7.7 10.2 0.73
Note: Captonocytophaga ochracea; Eikenella corrodens; Actinomyces naeslundii; Finegoldia magna are not listed due to insufficient variation after
adjusting for country.
*
Percentages and p-values for trend are adjusted for sex, age, country, and education.
**Oral bacterial species that have been previously associated with periodontal disease.
§
“High” defined as >200ng/mL, unless otherwise indicated with footnote.
‡due to small numbers with antibodies above 200ng/mL, the cutpoint was set at >50 ng/ml
^due to small numbers with antibodies above 50ng/mL, the cutpoint was set at >7.5 ng/ml.
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Table 3
Total antibody to 25 oral bacteria in apparently healthy individuals in the EPIC sub-cohort (n=395) in relation
to dietary factors*
Total IgG (ng/mL) P-values
Vegetable intake 0.61
Quartile 1 (lowest) 1888
Quartile 2 1748
Quartile 3 1760
Quartile 4 (highest) 1836
Fruit intake 0.49
Quartile 1 1869
Quartile 2 1892
Quartile 3 1760
Quartile 4 1837
Dairy intake 0.59
Quartile 1 1704
Quartile 2 1794
Quartile 3 1890
Quartile 4 1826
Vitamin C 0.50
Quartile 1 1840
Quartile 2 1918
Quartile 3 1739
Quartile 4 1884
Coffee intake 0.86
Quartile 1 1834
Quartile 2 1748
Quartile 3 1783
Quartile 4 1847
Alcohol intake 0.93
Quartile 1 1820
Quartile 2 1788
Quartile 3 1761
Quartile 4 1734
*
Means and p-values for trend are adjusted for sex, age, country, education, BMI and smoking status.
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